ReviewCancer management and research2021
Potential Prospect of CDK4/6 Inhibitors in Triple-Negative Breast Cancer.
Ye Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papercites it
ReviewCancer management and research2021
Ye Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.